At the time of writing, Biohaven Ltd [BHVN] stock is trading at $15.52, up 5.58%. An important factor to consider is whether the stock is rising or falling in short-term value. The BHVN shares have gain 10.31% over the last week, with a monthly amount glided 1.77%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biohaven Ltd [NYSE: BHVN] stock has seen the most recent analyst activity on September 17, 2025, when Citigroup initiated its Buy rating and assigned the stock a price target of $28. Previously, Raymond James started tracking the stock with Strong Buy rating on September 03, 2025, and set its price target to $75. On May 19, 2025, downgrade downgraded it’s rating to Sector Perform but maintained its price target of $21 on the stock. Deutsche Bank started tracking the stock assigning a Buy rating and suggested a price target of $65 on February 11, 2025. Jefferies initiated its recommendation with a Buy and recommended $57 as its price target on September 16, 2024. Bernstein started tracking with a Outperform rating for this stock on September 04, 2024, and assigned it a price target of $55. In a note dated July 24, 2024, Morgan Stanley initiated an Overweight rating and provided a target price of $58 on this stock.
For the past year, the stock price of Biohaven Ltd fluctuated between $12.79 and $55.70. Currently, Wall Street analysts expect the stock to reach $60 within the next 12 months. Biohaven Ltd [NYSE: BHVN] shares were valued at $15.52 at the most recent close of the market. An investor can expect a potential return of 286.6% based on the average BHVN price forecast.
Analyzing the BHVN fundamentals
Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -208.91%, Pretax Profit Margin comes in at -199.72%, and Net Profit Margin reading is -199.94%. To continue investigating profitability, this company’s Return on Assets is posted at -1.39, Equity is -2.71 and Total Capital is -1.88. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Biohaven Ltd [NYSE:BHVN] has a current ratio of 3.82. On the other hand, the Quick Ratio is 3.82, and the Cash Ratio is 1.33.
Transactions by insiders
Recent insider trading involved CHILDS JOHN W, Director, that happened on Mar 04 ’25 when 32700.0 shares were purchased. Director, CHILDS JOHN W completed a deal on Dec 30 ’24 to buy 29000.0 shares. Meanwhile, Director CHILDS JOHN W bought 21052.0 shares on Oct 02 ’24.
